Revue des publications scientifiques de novembre 2013

1. Very high blood lead levels among adults – United States, 2002-2011.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2013 Nov 29;62(47):967-71.
2. Triggering essential head tremor with sustained phonation: A clinical phenomenon with potential diagnostic value.
Wright BA, Michalec M, Louis ED.
Parkinsonism Relat Disord. 2013 Nov 12.
doi:pii: S1353-8020(13)00382-9. 10.1016/j.parkreldis.2013.10.019.
3. Physiological and anatomical decomposition of subthalamic neurostimulation effects in essential tremor.
Groppa S, Herzog J, Falk D, Riedel C, Deuschl G, Volkmann J.
Brain. 2013 Nov 25.
4. Dexterity Training Improves Manual Precision in Patients Affected by Essential Tremor.
Budini F, Lowery MM, Hutchinson M, Bradley D, Conroy L, De Vito G.
Arch Phys Med Rehabil. 2013 Nov 22.
doi:pii: S0003-9993(13)01154-4. 10.1016/j.apmr.2013.11.002.
5. Quantitative Methods for Evaluating the Efficacy of Thalamic Deep Brain Stimulation in Patients with Essential Tremor.
Wastensson G, Holmberg B, Johnels B, Barregard L.
Tremor Other Hyperkinet Mov (N Y). 2013 Nov 4;3.
doi:pii: tre-03-196-4279-2.
6. Four Essential Tremor Cases with Moderately Impaired Gait: How Impaired can Gait be in this Disease?
Louis ED, Galecki M, Rao AK.
Tremor Other Hyperkinet Mov (N Y). 2013 Nov 4;3.
doi:pii: tre-03-200-4597-1.
7. Risks of common complications in deep brain stimulation surgery: management and avoidance.
Fenoy AJ, Simpson RK Jr.
J Neurosurg. 2013 Nov 15.
8. The cognitive side of essential tremor: what are the therapeutic implications?
Janicki SC, Cosentino S, Louis ED.
Ther Adv Neurol Disord. 2013 Nov;6(6):353-68.
doi: 10.1177/1756285613489591.
9. MR-Guided, Focused Ultrasound: Applications to Essential Tremor and Other Neurologic Conditions.
Suffredini G, Levy LM.
AJNR Am J Neuroradiol. 2013 Nov 7.
10. Research Highlights: Highlights from the latest articles in essential tremor biomarkers and pharmacogenomics.
Agúndez JA, Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E.
Pharmacogenomics. 2013 Nov;14(14):1679-82.
doi: 10.2217/pgs.13.168.
11. The use of magnetic resonance-guided high intensity focused ultrasound to treat essential tremor.
Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Frysinger R, Sperling S, Wylie S, Monteith S, Druzgal J, Shah B, Harrison M, Wintermark M.
J Acoust Soc Am. 2013 Nov;134(5):4090.
doi: 10.1121/1.4830938.
12. Facial emotion recognition is inversely correlated with tremor severity in essential tremor.
Auzou N, Foubert-Samier A, Dupouy S, Meissner WG.
J Neural Transm. 2013 Nov 1.
13. Deep brain stimulation: a mechanistic and clinical update.
Karas PJ, Mikell CB, Christian E, Liker MA, Sheth SA.
Neurosurg Focus. 2013 Nov;35(5):E1.
doi: 10.3171/2013.9.FOCUS13383.
14. Focused ultrasound thalamotomy improves essential tremor.
Hariz M.
Mov Disord. 2013 Nov;28(13):1803.
doi: 10.1002/mds.25695.
15. Is essential tremor a Purkinjopathy? The role of the cerebellar cortex in its pathogenesis.
Grimaldi G, Manto M.
Mov Disord. 2013 Nov;28(13):1759-61.
doi: 10.1002/mds.25645.
16. Orthostatic tremor, progressive external ophthalmoplegia, and twinkle.
Milone M, Klassen BT, Landsverk ML, Haas RH, Wong LJ.
JAMA Neurol. 2013 Nov 1;70(11):1429-31.
doi: 10.1001/jamaneurol.2013.3521.
17. The evolving role of diffusion magnetic resonance imaging in movement disorders.
Hess CW, Ofori E, Akbar U, Okun MS, Vaillancourt DE.
Curr Neurol Neurosci Rep. 2013 Nov;13(11):400.
doi: 10.1007/s11910-013-0400-1.
18. Task force report: Scales for screening and evaluating tremor: Critique and recommendations.
Elble R, Bain P, João Forjaz M, Haubenberger D, Testa C, Goetz CG, Leentjens AF, Martinez-Martin P, Pavy-Le Traon A, Post B, Sampaio C, Stebbins GT, Weintraub D, Schrag A.
Mov Disord. 2013 Nov;28(13):1793-800.
doi: 10.1002/mds.25648.
19. Is there a one-way street from essential tremor to Parkinson’s disease? Possible biological ramifications.
Louis ED, Ottman R.
Eur J Neurol. 2013 Nov;20(11):1440-4.
doi: 10.1111/ene.12256.
20. No association of the SLC1A2 rs3794087 allele with risk for essential tremor in the Spanish population.
García-Martín E, Martínez C, Alonso-Navarro H, Benito-León J, Lorenzo-Betancor O, Pastor P, Ortega-Cubero S, López-Alburquerque T, Agúndez JA, Jiménez-Jiménez FJ.
Pharmacogenet Genomics. 2013 Nov;23(11):587-90.
doi: 10.1097/FPC.0b013e328364db9d.
21. Safety and efficacy of botulinum toxin in primary orthostatic tremor.
Bertram K, Sirisena D, Cowey M, Hill A, Williams DR.
J Clin Neurosci. 2013 Nov;20(11):1503-5.
doi: 10.1016/j.jocn.2012.12.025.
22. Quantification of cerebellar hemispheric purkinje cell linear density: 32 ET cases versus 16 controls.
Louis ED, Babij R, Lee M, Cortés E, Vonsattel JP.
Mov Disord. 2013 Nov;28(13):1854-9.
doi: 10.1002/mds.25629.
23. Orthostatic myoclonus: An underrecognized cause of unsteadiness?
Gasca-Salas C, Arcocha J, Artieda J, Pastor P.
Parkinsonism Relat Disord. 2013 Nov;19(11):1013-7.
doi: 10.1016/j.parkreldis.2013.07.004.
24. Diffusion tensor imaging of Parkinson’s disease, atypical parkinsonism, and essential tremor.
Prodoehl J, Li H, Planetta PJ, Goetz CG, Shannon KM, Tangonan R, Comella CL, Simuni T, Zhou XJ, Leurgans S, Corcos DM, Vaillancourt DE.
Mov Disord. 2013 Nov;28(13):1816-22.
doi: 10.1002/mds.25491.
25. Cognitive effects of deep brain stimulation for essential tremor: evaluation at 1 and 6 years.
Heber IA, Coenen VA, Reetz K, Schulz JB, Hoellig A, Fimm B, Kronenbuerger M.
J Neural Transm. 2013 Nov;120(11):1569-77.
doi: 10.1007/s00702-013-1030-0.
26. [Elaboration of the SPM template for the standardization of SPECT images with (123)I-Ioflupane].
García-Gómez FJ, García-Solís D, Luis-Simón FJ, Marín-Oyaga VA, Carrillo F, Mir P, Vázquez-Albertino RJ.
Rev Esp Med Nucl Imagen Mol. 2013 Nov-Dec;32(6):350-6.
doi: 10.1016/j.remn.2013.02.009.
27. Autopsy report of a 7-year old patient with the mosaic trisomy 13.
Imataka G, Yamanouchi H, Hirato J, Eguchi M, Kojima M, Honma K, Arisaka O.
Cell Biochem Biophys. 2013 Nov;67(2):813-7.
doi: 10.1007/s12013-013-9567-y.
28. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.
Bajaj N, Hauser RA, Grachev ID.
J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1288-95.
doi: 10.1136/jnnp-2012-304436.